131 related articles for article (PubMed ID: 8045141)
21. Cost-effectiveness of HA-1A monoclonal antibody for gram-negative sepsis. Economic assessment of a new therapeutic agent.
Schulman KA; Glick HA; Rubin H; Eisenberg JM
JAMA; 1991 Dec; 266(24):3466-71. PubMed ID: 1744962
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the efficacy, safety, and therapeutic usage of HA-1A and E5 in the treatment of gram-negative sepsis.
Quintiliani R; Cooper B; Maderazo E; Nightingale C
Hosp Formul; 1992 Jan; 27(1):49-52, 54, 57-60. PubMed ID: 10116116
[TBL] [Abstract][Full Text] [Related]
23. Long-term survival and function after suspected gram-negative sepsis.
Perl TM; Dvorak L; Hwang T; Wenzel RP
JAMA; 1995 Jul; 274(4):338-45. PubMed ID: 7609265
[TBL] [Abstract][Full Text] [Related]
24. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group.
Greenman RL; Schein RM; Martin MA; Wenzel RP; MacIntyre NR; Emmanuel G; Chmel H; Kohler RB; McCarthy M; Plouffe J
JAMA; 1991 Aug; 266(8):1097-102. PubMed ID: 1865542
[TBL] [Abstract][Full Text] [Related]
25. E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators.
Angus DC; Birmingham MC; Balk RA; Scannon PJ; Collins D; Kruse JA; Graham DR; Dedhia HV; Homann S; MacIntyre N
JAMA; 2000 Apr; 283(13):1723-30. PubMed ID: 10755499
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of monoclonal antibodies to gram-negative endotoxin in the treatment of gram-negative sepsis in ICU patients.
Chalfin DB; Holbein ME; Fein AM; Carlon GC
JAMA; 1993 Jan; 269(2):249-54. PubMed ID: 8417245
[TBL] [Abstract][Full Text] [Related]
27. The French National Registry of HA-1A (Centoxin) in septic shock. A cohort study of 600 patients. The National Committee for the Evaluation of Centoxin.
Arch Intern Med; 1994 Nov; 154(21):2484-91. PubMed ID: 7979845
[TBL] [Abstract][Full Text] [Related]
28. Hemodynamic responses to gram-positive versus gram-negative sepsis in critically ill patients with and without circulatory shock.
Ahmed AJ; Kruse JA; Haupt MT; Chandrasekar PH; Carlson RW
Crit Care Med; 1991 Dec; 19(12):1520-5. PubMed ID: 1959372
[TBL] [Abstract][Full Text] [Related]
29. HA-1A. A human monoclonal antibody for the treatment of gram-negative sepsis.
Smith CR; Straube RC; Ziegler EJ
Infect Dis Clin North Am; 1992 Mar; 6(1):253-66. PubMed ID: 1578120
[TBL] [Abstract][Full Text] [Related]
30. Observations using antiendotoxin antibody (E5) as adjuvant therapy in humans with suspected, serious, gram-negative sepsis.
Greenberg RN; Wilson KM; Kunz AY; Wedel NI; Gorelick KJ
Crit Care Med; 1992 Jun; 20(6):730-5. PubMed ID: 1597023
[TBL] [Abstract][Full Text] [Related]
31. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Bakker J; Grover R; McLuckie A; Holzapfel L; Andersson J; Lodato R; Watson D; Grossman S; Donaldson J; Takala J;
Crit Care Med; 2004 Jan; 32(1):1-12. PubMed ID: 14707554
[TBL] [Abstract][Full Text] [Related]
32. Anti-ovine interleukin-1beta monoclonal antibody immunotherapy in an ovine model of gram-negative septic shock.
Peake SL; Pierides J; Leppard PI; Russ GR
Crit Care Med; 2002 Jan; 30(1):171-81. PubMed ID: 11902259
[TBL] [Abstract][Full Text] [Related]
33. Initial evaluation of a human immunoglobulin M monoclonal antibody (HA-1A) in humans.
Khazaeli MB; Wheeler R; Rogers K; Teng N; Ziegler E; Haynes A; Saleh MN; Hardin JM; Bolmer S; Cornett J
J Biol Response Mod; 1990 Apr; 9(2):178-84. PubMed ID: 2341860
[TBL] [Abstract][Full Text] [Related]
34. Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group.
Derkx B; Wittes J; McCloskey R
Clin Infect Dis; 1999 Apr; 28(4):770-7. PubMed ID: 10825037
[TBL] [Abstract][Full Text] [Related]
35. Single-dose pharmacokinetics and safety of HA-1A, a human IgM anti-lipid-A monoclonal antibody, in pediatric patients with sepsis syndrome.
Romano MJ; Kearns GL; Kaplan SL; Jacobs RF; Killian A; Bradley JS; Moss MM; Van Dyke R; Rodriguez W; Straube RC
J Pediatr; 1993 Jun; 122(6):974-81. PubMed ID: 8501580
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
[TBL] [Abstract][Full Text] [Related]
37. Life-saving immunotherapy with cross-reactive monoclonal antibodies against endotoxin: a critical evaluation of experimental and clinical studies.
Cornelissen JJ; Schellekens JF; Kraaijeveld CA; Verhoef J
Neth J Med; 1991 Oct; 39(3-4):170-6. PubMed ID: 1791879
[TBL] [Abstract][Full Text] [Related]
38. Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group.
Dhainaut JF; Tenaillon A; Le Tulzo Y; Schlemmer B; Solet JP; Wolff M; Holzapfel L; Zeni F; Dreyfuss D; Mira JP
Crit Care Med; 1994 Nov; 22(11):1720-8. PubMed ID: 7956274
[TBL] [Abstract][Full Text] [Related]
39. Multicenter evaluation of a human monoclonal antibody to Enterobacteriaceae common antigen in patients with Gram-negative sepsis.
Albertson TE; Panacek EA; MacArthur RD; Johnson SB; Benjamin E; Matuschak GM; Zaloga G; Maki D; Silverstein J; Tobias JK; Haenftling K; Black G; Cowens JW;
Crit Care Med; 2003 Feb; 31(2):419-27. PubMed ID: 12576946
[TBL] [Abstract][Full Text] [Related]
40. Effects of titrated arginine vasopressin on hemodynamic variables and oxygen transport in healthy and endotoxemic sheep.
Westphal M; Stubbe H; Sielenkämper AW; Ball C; Van Aken H; Borgulya R; Bone HG
Crit Care Med; 2003 May; 31(5):1502-8. PubMed ID: 12771625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
